First Time Loading...

Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 151.17 USD 1.84% Market Closed
Updated: Mar 29, 2024

Wall Street
Price Targets

ASND Price Targets Summary
Ascendis Pharma A/S

Wall Street analysts forecast ASND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASND is 175.64 USD with a low forecast of 117.16 USD and a high forecast of 236.25 USD.

Lowest
Price Target
117.16 USD
22% Downside
Average
Price Target
175.64 USD
16% Upside
Highest
Price Target
236.25 USD
56% Upside

ASND Last Price Targets
Ascendis Pharma A/S

The latest public price target was made on Mar 14, 2024 by Josh Schimmer from Evercore ISI , who expects ASND stock to rise by 26% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Josh Schimmer
Evercore ISI
191 USD
Upside 26%
2 weeks ago
Mar 14, 2024
Ascendis Pharma (ASND) PT Raised to $191 at Evercore ISI
StreetInsider
Josh Schimmer
Evercore ISI
Price Target 191 USD
Upside/Downside 26%
View Source
Ascendis Pharma A/S Competitors:
Price Targets
ARWR
Arrowhead Pharmaceuticals Inc
98% Upside
DVAX
Dynavax Technologies Corp
112% Upside
EXAI
Exscientia PLC
55% Upside
SGEN
Seagen Inc
0% Upside
ALACT
Acticor Biotech SA
215% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
14% Downside
145020
Hugel Inc
10% Upside
6160
Beigene Ltd
54% Upside

Revenue
Forecast

Revenue Estimate
Ascendis Pharma A/S

For the last 8 years the compound annual growth rate for Ascendis Pharma A/S's revenue is 55%. The projected CAGR for the next 3 years is 64%.

55%
Past Growth
64%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ascendis Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascendis Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASND's stock price target?
Price Target
175.64 USD

According to Wall Street analysts, the average 1-year price target for ASND is 175.64 USD with a low forecast of 117.16 USD and a high forecast of 236.25 USD.

What is Ascendis Pharma A/S's Revenue forecast?
Projected CAGR
64%

For the last 8 years the compound annual growth rate for Ascendis Pharma A/S's revenue is 55%. The projected CAGR for the next 3 years is 64%.